Literature DB >> 19969003

PCP consensus sequences of flaviviruses: correlating variance with vector competence and disease phenotype.

Petr Danecek1, Wenzhe Lu, Catherine H Schein.   

Abstract

BACKGROUND: Computational methods are needed to design multivalent vaccines against flaviviruses (FVs) such as the West Nile virus or the dengue virus (DENV).
OBJECTIVE: We aimed to use physicochemical property (PCP) consensus sequences of FV strains to delineate conserved motifs, areas of maximum variability, and specific loci that correlate with arthropod vector, serotype, and disease severity.
METHODS: PCP consensus sequences for 27 species were prepared from 928 annotated sequences catalogued in Flavitrack. Alignments of these correlated well with the known structures of the NS3 protease domain and envelope (E) proteins. The PCPMer suite was used to identify motifs common to all FVs. Areas of PCP variability that correlated with phenotype were plotted on the structures.
RESULTS: Despite considerable diversity at the amino acid level, PCPs for both proteins were well conserved throughout the FVs. A series of insertions in E separated tick- from mosquito-borne viruses and all arthropod-borne viruses from isolates with no known vector or directly from insects. Comparison of a PCP consensus sequence of E derived from 600 DENV strains (DENV600) with individual ones for DENV1-DENV4 showed that most major serotype-specific variation occurs near these insertions. The DENV600 differed from one prepared from eight hemorrhagic or fatal strains from four DENV serotypes at only three positions, two of which overlap known escape mutant sites.
CONCLUSIONS: Comparing consensus sequences showed that substantial changes occur in only a few areas of the E protein. PCP consensus sequences can contribute to the design of multivalent vaccines. Copyright (c) 2009. Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19969003      PMCID: PMC2822003          DOI: 10.1016/j.jmb.2009.11.070

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  68 in total

1.  Flavitrack: an annotated database of flavivirus sequences.

Authors:  Milind Misra; Catherine H Schein
Journal:  Bioinformatics       Date:  2007-07-28       Impact factor: 6.937

2.  Partial agonist effect influences the CTL response to a heterologous dengue virus serotype.

Authors:  J Zivny; M DeFronzo; W Jarry; J Jameson; J Cruz; F A Ennis; A L Rothman
Journal:  J Immunol       Date:  1999-09-01       Impact factor: 5.422

3.  Dengue virus structural differences that correlate with pathogenesis.

Authors:  K C Leitmeyer; D W Vaughn; D M Watts; R Salas; I Villalobos; C Ramos; R Rico-Hesse
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

4.  Molego-based definition of the architecture and specificity of metal-binding sites.

Authors:  Catherine H Schein; Bin Zhou; Numan Oezguen; Venkatarajan S Mathura; Werner Braun
Journal:  Proteins       Date:  2005-01-01

5.  Identification of new flaviviruses in the Kokobera virus complex.

Authors:  Debra J Nisbet; Katie J Lee; Andrew F van den Hurk; Cheryl A Johansen; Goro Kuno; Gwong-Jen J Chang; John S Mackenzie; Scott A Ritchie; Roy A Hall
Journal:  J Gen Virol       Date:  2005-01       Impact factor: 3.891

6.  Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection.

Authors:  Jang-Hann J Chu; Cern-Cher S Chiang; Mah-Lee Ng
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

7.  Induction of epitope-specific neutralizing antibodies against West Nile virus.

Authors:  Theodore Oliphant; Grant E Nybakken; S Kyle Austin; Qing Xu; Jonathan Bramson; Mark Loeb; Mark Throsby; Daved H Fremont; Theodore C Pierson; Michael S Diamond
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

8.  Dengue virus evolution and virulence models.

Authors:  Rebeca Rico-Hesse
Journal:  Clin Infect Dis       Date:  2007-04-18       Impact factor: 9.079

9.  Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes.

Authors:  Soila Sukupolvi-Petty; S Kyle Austin; Whitney E Purtha; Theodore Oliphant; Grant E Nybakken; Jacob J Schlesinger; John T Roehrig; Gregory D Gromowski; Alan D Barrett; Daved H Fremont; Michael S Diamond
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

Review 10.  Current use and development of vaccines for Japanese encephalitis.

Authors:  David W C Beasley; Penny Lewthwaite; Tom Solomon
Journal:  Expert Opin Biol Ther       Date:  2008-01       Impact factor: 4.388

View more
  13 in total

1.  NMR solution structure of poliovirus uridylyated peptide linked to the genome (VPgpU).

Authors:  Catherine H Schein; Numan Oezguen; Gerbrand J van der Heden van Noort; Dmitri V Filippov; Aniko Paul; Eric Kumar; Werner Braun
Journal:  Peptides       Date:  2010-05-02       Impact factor: 3.750

2.  Simplifying complex sequence information: a PCP-consensus protein binds antibodies against all four Dengue serotypes.

Authors:  David M Bowen; Jessica A Lewis; Wenzhe Lu; Catherine H Schein
Journal:  Vaccine       Date:  2012-07-31       Impact factor: 3.641

3.  Allosteric inhibitors of Coxsackie virus A24 RNA polymerase.

Authors:  Catherine H Schein; Diane Rowold; Kyung H Choi
Journal:  Bioorg Med Chem       Date:  2015-12-15       Impact factor: 3.641

4.  Identification of conserved motifs in the West Nile virus envelope essential for particle secretion.

Authors:  Himanshu Garg; Raphael T C Lee; Ng Oon Tek; Sebastian Maurer-Stroh; Anjali Joshi
Journal:  BMC Microbiol       Date:  2013-09-04       Impact factor: 3.605

5.  Designing multivalent immunogens for alphavirus vaccine optimization.

Authors:  C M Read; Kenneth Plante; Grace Rafael; Shannan L Rossi; Werner Braun; Scott C Weaver; Catherine H Schein
Journal:  Virology       Date:  2021-02-05       Impact factor: 3.513

6.  Dengue virus antibody database: Systematically linking serotype-specificity with epitope mapping in dengue virus.

Authors:  Sidhartha Chaudhury; Gregory D Gromowski; Daniel R Ripoll; Ilja V Khavrutskii; Valmik Desai; Anders Wallqvist
Journal:  PLoS Negl Trop Dis       Date:  2017-02-21

7.  Dengue virus type 3 adaptive changes during epidemics in São Jose de Rio Preto, Brazil, 2006-2007.

Authors:  Christian Julian Villabona-Arenas; Adriano Mondini; Irene Bosch; Diane J Schimdt; Diane Schimitt; Carlos E Calzavara-Silva; Paolo M de A Zanotto; Maurício L Nogueira
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

8.  Physicochemical property consensus sequences for functional analysis, design of multivalent antigens and targeted antivirals.

Authors:  Catherine H Schein; David M Bowen; Jessica A Lewis; Kyung Choi; Aniko Paul; Gerbrand J van der Heden van Noort; Wenzhe Lu; Dmitri V Filippov
Journal:  BMC Bioinformatics       Date:  2012-08-24       Impact factor: 3.169

9.  A High-Performance Multiplex Immunoassay for Serodiagnosis of Flavivirus-Associated Neurological Diseases in Horses.

Authors:  Cécile Beck; Philippe Desprès; Sylvie Paulous; Jessica Vanhomwegen; Steeve Lowenski; Norbert Nowotny; Benoit Durand; Annabelle Garnier; Sandra Blaise-Boisseau; Edouard Guitton; Takashi Yamanaka; Stéphan Zientara; Sylvie Lecollinet
Journal:  Biomed Res Int       Date:  2015-09-17       Impact factor: 3.411

10.  Cross-reactivities between human IgMs and the four serotypes of dengue virus as probed with artificial homodimers of domain-III from the envelope proteins.

Authors:  Nora Zidane; Philippe Dussart; Laetitia Bremand; Hugues Bedouelle
Journal:  BMC Infect Dis       Date:  2013-07-01       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.